A study of INT-747 (6-ethyl chenodeoxycholic acid [6-ECDCA]) in combination with ursodeoxycholic acid (UDCA [URSO®]) in patients with primary biliary cirrhosis (PBC)

Completed Not Applicable ISRCTN67465025

Study Description

Not provided at time of registration

Study Details

Registry ID:
ISRCTN67465025
Conditions:
Primary biliary cirrhosis, Digestive System
Phase:
Not Applicable
Target Enrollment:
140 participants
Start Date:
Healthy Volunteers:
No

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.

View full study details and check eligibility →